IDT Australia Ltd banner

IDT Australia Ltd
ASX:IDT

Watchlist Manager
IDT Australia Ltd Logo
IDT Australia Ltd
ASX:IDT
Watchlist
Price: 0.045 AUD -4.26% Market Closed
Market Cap: AU$19.2m

IDT Australia Ltd
Investor Relations

IDT Australia Ltd. produces, develops and supplies pharmaceutical products. The company is headquartered in Melbourne, Victoria. The firm is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. The firm specializes in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging and pharmacy services. The company provides services for new drug development and scale-up, commercial active drug manufacture as well as a various oral and injectable finished drug dose forms. Its sterile manufacturing suite is designed to liquid fill and lyophilise a range of sterile pharmaceutical and biopharmaceutical drug products. Its current goods manufacturing practices (cGMP) facilities manufactures a range of medicinal cannabis products for local and international markets.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Paul Anthony McDonald
Chief Executive Officer
No Bio Available
Mr. Vasanthakumar Mahendran
Chief Financial Officer
No Bio Available
Mr. Jim Sosic
Chief Operating Officer
No Bio Available
Mr. Marc Flanders
Director of Commercial, Business Development & Global Sales
No Bio Available
Ms. Paula Coutts
Head of People & Safety
No Bio Available
Ms. Priscilla Thiyageas
Quality Director
No Bio Available
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP
Company Secretary
No Bio Available

Contacts

Address
VICTORIA
Melbourne
45 Wadhurst Dr, Boronia
Contacts
+61398018888.0
www.idtaus.com.au